Status:

ACTIVE_NOT_RECRUITING

A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Healthy

Obesity

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

The goal of this study is to find out whether different formulations of survodutide given by different delivery methods is taken up in the body in a similar way. Participants visit the study site reg...

Eligibility Criteria

Inclusion Criteria:

  1. Male or female trial participant who is healthy or otherwise healthy with overweight/obesity according to the assessment of the investigator, as based on a complete medical history including a physical examination, vital signs (blood pressure (BP), pulse rate (PR)), 12-lead electrocardiogram (ECG), and clinical laboratory tests
  2. Age of 18 to 55 years (inclusive)
  3. Body mass index (BMI) of 22.0 to 39.9 kg/m2 (inclusive)
  4. Signed and dated written informed consent in accordance with international council for harmonisation-good clinical practice (ICH-GCP) and local legislation prior to admission to the trial Further inclusion criteria apply.

Exclusion Criteria:

  1. Any finding in the medical examination (including BP, PR or ECG) deviating from normal and assessed as clinically relevant by the investigator
  2. Repeated measurement of systolic BP outside the range of 90 to 140 millimetre of mercury (mmHg), diastolic BP outside the range of 50 to 90 mmHg, or PR outside the range of 45 to 90 beats per minute (bpm)
  3. Any laboratory value outside the reference range that the investigator considers to be of clinical relevance
  4. Any evidence of a concomitant disease assessed as clinically relevant by the investigator Further exclusion criteria apply.

Key Trial Info

Start Date :

March 3 2026

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 8 2026

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT07413913

Start Date

March 3 2026

End Date

June 8 2026

Last Update

April 17 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Humanpharmakologisches Zentrum Biberach

Biberach, Germany, 88397